Apella Capital, LLC Bristol Myers Squibb CO Transaction History

Apella Capital, LLC

$2.41 Billion
Q3 2024

A detailed history of Apella Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Apella Capital, LLC holds 6,244 shares of BMY stock, worth $341,609. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,244

Previous 6,497 3.89%

Holding current value

$341,609

Previous $269,000 20.07%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$39.66 - $51.75 $10,033 - $13,092	-253 Reduced 3.89%	6,244 $323,000
Q2 2024 Jul 10, 2024	BUY	$40.25 - $52.99 $10,948 - $14,413	272 Added 4.37%	6,497 $269,000
Q1 2024 Apr 10, 2024	SELL	$47.98 - $54.4 $8,876 - $10,064	-185 Reduced 2.89%	6,225 $337,000
Q4 2023 Jan 05, 2024	SELL	$48.48 - $57.85 $22,300 - $26,611	-460 Reduced 6.7%	6,410 $328,000
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $22,113 - $24,726	-382 Reduced 5.27%	6,870 $398,000
Q2 2023 Jul 06, 2023	SELL	$63.71 - $70.74 $15,800 - $17,543	-248 Reduced 3.31%	7,252 $463,000
Q4 2022 Jan 10, 2023	BUY	$68.48 - $81.09 $156,956 - $185,858	2,292 Added 44.01%	7,500 $0
Q3 2022 Oct 11, 2022	BUY	$0.13 - $76.84 $31 - $18,518	241 Added 4.85%	5,208 $370,000
Q2 2022 Jul 08, 2022	BUY	$72.62 - $79.98 $27,886 - $30,712	384 Added 8.38%	4,967 $382,000
Q1 2022 Apr 11, 2022	BUY	$61.48 - $73.72 $2,336 - $2,801	38 Added 0.84%	4,583 $334,000
Q4 2021 Jan 13, 2022	BUY	$53.63 - $62.52 $1,501 - $1,750	28 Added 0.62%	4,545 $283,000
Q3 2021 Oct 12, 2021	SELL	$59.17 - $69.31 $69,879 - $81,855	-1,181 Reduced 20.73%	4,517 $267,000
Q2 2021 Jan 18, 2022	SELL	$61.91 - $67.42 $495 - $539	-8 Reduced 0.14%	5,698 $381,000
Q2 2021 Jul 02, 2021	BUY	$61.91 - $67.42 $18,882 - $20,563	305 Added 5.65%	5,706 $381,000
Q1 2021 Apr 15, 2021	SELL	$59.34 - $66.74 $10,087 - $11,345	-170 Reduced 3.05%	5,401 $341,000
Q4 2020 Feb 18, 2021	SELL	$57.74 - $65.43 $56,296 - $63,794	-975 Reduced 14.89%	5,571 $346,000
Q3 2020 Oct 22, 2020	BUY	$57.43 - $63.64 $32,907 - $36,465	573 Added 9.59%	6,546 $395,000
Q2 2020 Jul 20, 2020	SELL	$54.82 - $64.09 $44,075 - $51,528	-804 Reduced 11.86%	5,973 $351,000
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $314,452 - $456,973	6,777 New	6,777 $378,000

Others Institutions Holding BMY

# of Institutions

2,468

Shares Held

1.5B

Call Options Held

29.6M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $116B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apella Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apella Capital, LLC with notifications on news.

Account

Apella Capital, LLC Bristol Myers Squibb CO Transaction History